BIO Ventures for Global Health Launches New Online Tool

Global Health Primer by Disease

This week BIO Ventures for Global Health launched a new online tool called the “Global Health Primer” which aims to be a clearinghouse of information geared to the biotech industry to encourage investments in neglected disease product development. The Primer identifies gaps in the product pipeline for these diseases helping to highlight areas where companies and others can add effort and make the most progress. Content for the tool includes:

  • Creation of drug target and vaccine technology profiles in addition to the neglected disease profiles. These profiles group products in development by drug target classes and vaccine technologies that may span multiple diseases.
  • Expansion of each disease profile to include drug target and vaccine technology analysis that spotlights opportunities for application to neglected tropical diseases.
  • Greater analysis of strengths, weaknesses, opportunities, and risks for products currently in development for neglected tropical diseases, as well as information on development tools that are available to facilitate new product development

Click here to check out the Global Health Primer for TB

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...